« All Blogs Mar 9, 2016
CoC Requirements for Pediatric Cancer Programs

In January, I posted about the Commission on Cancer’s new edition of their requirements for Commission on Cancer accreditation. My post focused on the changes in the new edition and highlighted standards that cancer committee members should review closely.

In addition to the clarification and enhancements outlined in my January post, specifications for pediatric cancer programs are detailed in the updated standards manual. Highlights include: 

Standard 1.5 (Cancer Program Goals)
Pediatric cancer programs may choose to select only one goal (either clinical or programmatic) each calendar year.

Standards 4.1 (Cancer Prevention Programs) and 4.2 (Screening Programs)
Pediatric cancer program facilities are now required to conduct one prevention program and one screening program over the course of the three-year accreditation cycle. The community outreach activities should be focused on pediatric or adolescent-related cancer prevention and screening initiatives.

Standard 4.7 (Studies of Quality)
Two studies are required over the three-year accreditation cycle for pediatric cancer programs.

Standard 5.3 (Follow-Up of All Patients)
A 60 percent follow-up rate is now acceptable for all eligible analytic cases.

The following standards are exempt for pediatric cancer programs:

  • Standard 2.1 (CAP Protocols)
  • Standard 4.4 (Accountability Measures)
  • Standard 4.5 (Quality Improvement Measures)
  • Standard 4.6 (Monitoring Compliance with Evidence-Based Guidelines)
  • Standard 5.2 (RQRS Participation)

How does your pediatric cancer program monitor compliance with these standards? 

Partner with CHAMPS to Meet Commission on Cancer Standards.

« Previous Blog Post Colorectal Cancer is Preventable: Share the Message
Next Blog Post » Cancer Registry Operations: Caught in the daily routine?
About the Author

Ilona Gyerman, RHIT, CTR

Ilona Gyerman

20+ Years of Cancer Registry Experience

ASK ME ABOUT | CoC Accreditation, Survey Process, Data Quality, Cancer Registry Operations

See other articles by this author and view full bio »